MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -43.40% | 227.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -43.40% | 227.50% | |||
| Cost of Revenue | -0.47% | -10.86% | |||
| Gross Profit | -110.03% | 203.95% | |||
| SG&A Expenses | -6.76% | 6.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.62% | -8.13% | |||
| Operating Income | -164.91% | 150.70% | |||
| Income Before Tax | -188.76% | 146.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -184.15% | 146.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -184.15% | 146.40% | |||
| EBIT | -164.91% | 150.70% | |||
| EBITDA | -150.88% | 158.61% | |||
| EPS Basic | -184.10% | 146.33% | |||
| Normalized Basic EPS | -188.70% | 146.48% | |||
| EPS Diluted | -184.10% | 146.33% | |||
| Normalized Diluted EPS | -188.80% | 146.42% | |||
| Average Basic Shares Outstanding | 0.08% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||